Ezgi Kaya Aksoy, Sander Basten, Jolie Flach, Niels Meesters, Talita Stessuk, Luca Gandini, Emma Spanjaard, Leo Price and Nataliia Beztsinna
The intricate interactions between immune and tumor cells are essential in cancer immunotherapy research but are difficult to replicate accurately in vitro and in vivo. Traditional 2D cell cultures often fail to mimic the tumor microenvironment (TME) and the complexity of cancer-immune cell dynamics.
To address this gap, we have developed the 3D Ex Vivo Patient Tissue (EVPT) platform. This study compares the responses of ex vivo tumor samples from various indications, of which some are considered as “cold” or “hot”, to immuno-oncology therapies and explores the heterogeneity of responses across different cancer types in the EVPT platform.
Your privacy is important to us.
We'll never share your information.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences
© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-10-25
2024-10-04
landing_page
ENA 2024